GENERIC DRUGS MARKET ANALYSIS

Generic Drugs MarketSize and Trends

Market Taxonomy

The global generic drugs market is segmented on the basis of drug type, therapeutic application, route of administration, and region.

On the basis of Drug Type, the global generic drugs market is segmented into:

• Monoclonal Antibodies
• Cytokines
• Vaccines
• Insulin
• Peptide Hormones
• Immunoglobulin
• Peptide Antibiotics
• Blood Factors
• Others

On the basis of Therapeutic Application, the global generic drugs market is segmented into:

• Oncology
• Cardiovascular Diseases
• Neurology
• Infectious Diseases
• Musculoskeletal Diseases
• Others

Based on Route of Administration, the global generic drugs market is segmented into:

• Oral
• Topical
• Injectable
• Intra-venous
• Others

Asia Pacific to gain significant traction in the global generic drugs market owing to increasing number of local players

On the basis of region, the global generic drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America held a dominant position in the global generic drugs market in 2016. This is attributed to favorable regulatory policies that are revised and amended to encourage generic drugs business in the region. For instance, Generic Drug User Fee Amendment (GDFUA) was reauthorized in 2017 after its initiation in 2012 by FDA for increasing consumer access to high quality, safe, and affordable drugs. On the other hand, Asia Pacific is expected to show a significant traction in the market over the forecast period. This is attributed to lower manufacturing costs and high skilled workforce in the Asian countries. According to India Brand Equity Foundation, India has the second largest number of U.S. FDA manufacturing plants outside the U.S. that are involved in generic drugs manufacturing. Additionally, the cost of manufacturing is 33% lower in India than that in the U.S., increasing accessibility to generics in these countries.